Posts

Major Oslo Cancer Cluster delegation to Nordic Life Science Days/ECCP2014

The largest Nordic Life Science conference “Nordic Life Science Days” (NLSDays) will take place in Stockholm September 7-9. At present 652 delegates from 456 companies are registered – offering 339 licencing opportunities.

A large delegation from Oslo Cancer Cluster will join this years NLSDays that also features the European Cancer Cluster Partnering, which Oslo Cancer Cluster hosts together with French Cancer Bio-Santé.

17 members present
As of now, 17 Oslo Cancer Cluster member companies will be present at NLSDays/ECCP: APIM Therapeutics, Inven2, Nextera, Ultimovacs, Lifandis, Vaccibody, Norwegian Cancer Society, LINK Medical Research, Lytix Biopharma, Targovax, NTNU Technology Transfer, Oncoimmunity, Bergen Technology Transfer, Birk Venture, Oslo University Hospital, University of Oslo and PCI Biotech.

ECCP Oncology Track
The ECCP Oncology Track features a strong oncology program focusing on three major topics; early stage oncology possibilities, Immuno-Oncology and the coupling of biomarkers, bio banks and big data in cancer treatment. Major international speakers will join and the program covers the whole value chain from research to market.

Norwegian stand promoting Norwegian Healthcare Industry
Kindly sponsored by Innovation Norway, Oslo Cancer Cluster and Nansen Neuroscience Network organizes a joint conference booth promoting cluster members and the Norwegian Life Science sector. Please come and visit us to hear more about the strengths of Norwegian Healthcare Industry. The joint Norwegian Stand will be served by the Management Teams of both clusters.

More information www.nlsdays.com

 

NLSDAYS-ECCP 2014: Present your oncology innovation

Present your oncology innovation to the global life science industry at the largest partnering conference in the Nordics – Nordic Life Science Days featuring the 6th European Cancer Cluster Partnering (ECCP). Please note that application deadline is May 19th. 12 innovation projects will be selected to present a pitch.

ECCP and the Nordic Life Science Days features a special Oncology Track during the conference that takes place in Stockholm September 7-9 2014. NORTTH – The Nordic Tech Transfer Network/Health and the organizers invite researchers and oncology start-ups to apply to present their pre-commercial cancer projects to pharma industry and potential investors at the conference.

Great opportunity for oncology start-ups
12 pre-commercial cancer research projects will be selected by a review group consisting of oncology experts and technology transfer office representatives. Organizer Olav Steinnes from the largest Norwegian Tech-Transfer Office, Inven2, says: “This is a great opportunity for start-ups to promote their project, to receive feedback from the audience that can direct the research in the right commercial direction, and last but not least to connect to the key people. This event is above all a unique chance for investors to find the licensing opportunities of tomorrow.”

Criteria to be met:

  • Oncology related project (Rx or Dx)
  • Research conducted at a Nordic academic institution
  • Proof of principle demonstrated
  • Ambition to create a start-up or license out within the next 1-2 years

The application should be a maximum 2 page synopsis covering a short description of the technology and IPR situation, development status and planned project milestones over the next 2 years, description of product, intended use and target market.

Submit your application by May 19th, 2014 to olav.steinnes@inven2.com. Questions regarding the application may be directed to Olav Steinnes on Mobile +47 900 51 219 or E-mail: olav.steinnes@inven2.com.

Reduced rate
For registration and information about the NLSDays – ECCP 2014 please see www.nlsdays.se.
Oslo Cancer Cluster members receive a reduced special offer to participate – read more on this here.

Nordic Life Science Days and ECCP2014 merge

Oslo Cancer Cluster and French partner Cancer-Bio-Santé are joining forces with SwedenBio to offer the global Life Science industry the largest partnering conference in the Nordics – Nordic Life Science Days featuring the 6th European Cancer Cluster Partnering.

Already now oncology biotechs, early stage companies and academics may submit an application for presenting at NLSDays-ECCP 2014 – see more info here.

The 6th European Cancer Cluster Partnering (ECCP) will be integrated in the Nordic Life Science Days in Stockholm September 7. – 9, 2014 as a special Oncology track. Cancer clusters from different European countries have already indicated their interest to team-up for the combined ECCP Oncology stream and the joint event.

“This collaboration is an excellent opportunity to further strengthen the European Cancer Cluster Partnering Platform we have built together with our partner Cancer-Bio-Santé since 2009. The joint event offers enhanced partnering opportunities with more than 800 international delegates and allows us to bring ECCP to Scandinavia once again”, says Oslo Cancer Cluster’s international advisor Jutta Heix.

Olivier Duchamp, Managing Director for Nordic Life Science Days is extremely pleased with the success of last years’ event and says: “This year, our aim is to enhance the Nordic region furthermore and be very focused on recent trends and success stories. We obviously contribute an add-on value to the international partnering arena.”

The 2014 website is launched, and delegates are welcome to register at www.nlsdays.com. Download the press release from the web launch here (pdf).

About Nordic Life Science Days (NLSDays)
Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech, but also from finances, research, policy and regulatory authorities. It is the largest Nordic partnering conference for the global Life Science industry, bringing together the best talents in Life Science, offering the excellent networking and partnering opportunities, providing inputs and content on the most recent trends.

About European Cancer Cluster Partnering (ECCP)
Since 2009, ECCP – the European Cancer Cluster Partnering has been established as an annual partnering arena for the international oncology community. ECCP offers a vital networking arena and is the direct result of the close collaboration between two of Europe’s strongest cancer clusters, the French Cancer-Bio Santé Cluster and the Norwegian Oslo Cancer Cluster. The key goal of ECCP is building partnerships to accelerate innovation in cancer treatment.